Literature DB >> 16265998

Prevalence of cervical human papillomavirus in Taiwanese women.

Cherng-Jye Jeng1, Ma-Lee Ko, Qing-dong Ling, Jenta Shen, Hui-Wen Lin, Chii-Ruey Tzeng, Chih-Ming Ho, Tsai-Yen Chien, Su-Chee Chen.   

Abstract

PURPOSE: To define the prevalence rate of cervical human papilloma virus (HPV) using DNA oligonucleotide microarray and its correlation with risk factors in Taiwanese women in metropolitan Taipei.
METHODS: Thirteen hundred and twenty healthy women, aged 21 - 65 yr without history of cervical intraepithelial neoplasia (CIN) or carcinoma were included in this prospective study. Pap smear and HPV typing using oligonucleotide microarray were performed for each woman. They were given a standardized questionnaire to obtain information about the risk factors of cervical cancer in Taiwan.
RESULTS: The overall HPV positivity was 19.85% and multiple infections were found in 35.84% of the infected group, 7.92% of the whole study population. The younger the subject, the higher was the infection rate and multiple infection rates. The most common HPV types were 16, 18, 58, 52, 51 and 56, which is different from the western world. The sensitivity of the HPV DNA chip in detecting CIN and cervical carcinoma is 97.06%, and 100% in detecting CIN 2 or more lesions. Risk factors for HPV infection include earlier coitarche (P < 0.01), multiple sexual partners (P < 0.05), history of sexually transmitted disease (P < 0.05), two or more vaginal deliveries (P < 0.05) and infrequent use of condoms (P < 0.05). The association between oral contraception or cigarette smoking and HPV infection could not be determined because few women smoke or used oral contraception. There was no relationship between induced abortion and HPV infection.
CONCLUSIONS: About one-fifth of adult women in metropolitan Taipei were cervical HPV positive. The popular HPV types and the risk factors of HPV infection in metropolitan Taipei are not the same as those in the western world. The sensitivity of the HPV DNA chip in detecting cervical neoplasia is very high.

Entities:  

Mesh:

Year:  2005        PMID: 16265998

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  6 in total

1.  Factors associated with future commitment and past history of human papilloma virus vaccination among female college students in northern Taiwan.

Authors:  Ping-Fen Kuo; Ying-Tse Yeh; Shuh-Jen Sheu; Tze-Fang Wang
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401

2.  Comparisons of Papanicolaou Utilization and Cervical Cancer Detection between Rural and Urban Women in Taiwan.

Authors:  Chiu-Ming Yang; Fung-Chang Sung; Chao-Song Hsue; Chih-Hsin Muo; Shu-Wei Wang; Shwn-Huey Shieh
Journal:  Int J Environ Res Public Health       Date:  2020-12-28       Impact factor: 3.390

3.  Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.

Authors:  Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2010-01-11       Impact factor: 2.655

4.  Prevalence of human papillomavirus in Indonesia: a population-based study in three regions.

Authors:  J N I Vet; M A de Boer; B E W M van den Akker; B Siregar; S Budiningsih; D Tyasmorowati; S Cornain; A A W Peters; G J Fleuren
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

5.  Molecular Epidemiology of High-Risk Types of Human Papillomaviruses (16, 18) in Pap-Smear, the North East of Iran.

Authors:  A Moradi; S Bakhshandeh Nosrat; S Besharat
Journal:  Iran J Cancer Prev       Date:  2011

6.  A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993-2008.

Authors:  Tong Wang; Ming-Hui Wu; Yu-Mei Wu; Wei-Yuan Zhang
Journal:  Chin Med J (Engl)       Date:  2015-12-20       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.